SoCalBio Annual Investor & Partnering Conference Celebrates its 26th Successful Year as Greater Los Angeles’ Biotech/Medtech Industry’s Most Influential Event
29 oct. 2024 10h00 HE
|
Southern California Biomedical Council
LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Southern California Biomedical Council (SoCalBio) is proud to conclude the 2024 26th Annual Investor & Partnering Conference in Newport Beach, held...
SoCalBio’s 26th Annual Two-Day Investor Partnership Conference hosted at the Hyatt Regency Newport Beach for the Medical Device and Biotechnology Industry
18 sept. 2024 13h14 HE
|
Southern California Biomedical Council
The Southern California Biomedical Council announced the full lineup of speakers and presenting companies for its 26th Annual SoCalBio Investor Conference.
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
20 juin 2024 08h00 HE
|
Centogene NV
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug...
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
14 mai 2024 08h30 HE
|
Centogene NV
CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued...
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
10 mai 2024 06h30 HE
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 10, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
ESG Research Unveils Critical Gaps in Responsible AI Practices Across Industries
24 avr. 2024 08h30 HE
|
Qlik Technologies, Inc.
Comprehensive Study Highlights the Imperative for Enhanced AI Governance, Transparency, and Collaboration PHILADELPHIA, April 24, 2024 (GLOBE NEWSWIRE) -- Qlik®, a global leader in data...
NBME Recognizes Dr. Karen Hauer with Prestigious Medical Education Research Award
02 avr. 2024 10h21 HE
|
NBME
PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field...
Muscular Dystrophy Association Announces Recipient of 2024 MDA Legacy Award for Achievement in Research, is Jeffrey Chamberlain, Ph.D., Leading Professor in Gene Therapy
30 janv. 2024 09h59 HE
|
Muscular Dystrophy Association
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Jeffrey Chamberlain, Ph.D., a leading professor in gene therapy focused on Duchenne muscular...
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
25 janv. 2024 06h30 HE
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare...
CENTOGENE Receives French Research Tax Credit Accreditation
24 janv. 2024 06h30 HE
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...